Compare RAAQ & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAAQ | DERM |
|---|---|---|
| Founded | 2024 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 240.3M | 267.4M |
| IPO Year | N/A | 2021 |
| Metric | RAAQ | DERM |
|---|---|---|
| Price | $10.60 | $7.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.67 |
| AVG Volume (30 Days) | ★ 217.1K | 94.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,134,000.00 |
| Revenue This Year | N/A | $17.48 |
| Revenue Next Year | N/A | $55.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.62 | $5.40 |
| 52 Week High | $10.80 | $9.56 |
| Indicator | RAAQ | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 35.64 |
| Support Level | $10.22 | $6.77 |
| Resistance Level | $10.73 | $8.02 |
| Average True Range (ATR) | 0.11 | 0.49 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 40.33 | 3.92 |
Real Asset Acquisition Corp is a blank check company.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.